Primary Cutaneous CD30(+) Lymphoproliferative Disorders

被引:14
作者
Calzado-Villarreal, L. [1 ]
Polo-Rodriguez, I. [2 ]
Ortiz-Romero, P. L. [2 ]
机构
[1] Hosp Univ, Fdn Alcorcon, Unidad Dermatol, Madrid, Spain
[2] Hosp Univ, Serv Dermatol, 12 Octubre, Madrid, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2010年 / 101卷 / 02期
关键词
Cutaneous lymphomas; CD30(+) lymphoproliferative disorders; Lymphomatoid papulosis; CD30(+) anaplastic large-cell lymphomas;
D O I
10.1016/j.ad.2009.07.019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
CD30(+) lymphoproliferative disorders are the most common group of cutaneous T-cell lymphomas after mycosis fungoides and its subtypes. This group includes lymphomatoid papulosis and CD30(+) anaplastic large-cell lymphoma; these 2 entities are the extremes of a spectrum with numerous intermediate varieties in which it is not possible to establish a clear diagnosis based on clinical and histopathologic criteria. CD30(+) lymphoproliferative disorders must be differentiated from other lymphoproliferative diseases with CD30(+) cells in the tumor infiltrates, such as mycosis fungoides or Hodgkin disease, and also from other inflammatory conditions or nonhematological neoplasms that can include this cell type, such as pityriasis lichenoides et varioliformis acuta or certain mesenchymal tumors (CD30(+) pseudolymphomas). In contrast to their systemic homologues, which arise in the lymph nodes, CD30(+) lymphoproliferative disorders generally have a good prognosis. It is very important to exclude the presence of a lymphoma of systemic origin with extralymphatic spread, as the prognosis and treatment are different. (C) 2009 Elsevier Espana, S.L. and AEDV. All rights reserved.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 30 条
  • [1] [Anonymous], 1989, LEUKEMIA
  • [2] A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies
    Bartlett, Nancy L.
    Younes, Anas
    Carabasi, Matthew H.
    Forero, Andres
    Rosenblatt, Joseph D.
    Leonard, John P.
    Bernstein, Steven H.
    Bociek, R. Gregory
    Lorenz, Jennie M.
    Hart, Bruce W.
    Barton, Jeremy
    [J]. BLOOD, 2008, 111 (04) : 1848 - 1854
  • [3] Primary and secondary cutaneous CD30+ lymphoproliferative disorders:: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
    Bekkenk, MW
    Geelen, FAMJ
    Vader, PCV
    Heule, F
    Geerts, ML
    van Vloten, WA
    Meijer, CJLM
    Willemze, R
    [J]. BLOOD, 2000, 95 (12) : 3653 - 3661
  • [4] HODGKINS-DISEASE, LYMPHOMATOID PAPULOSIS, AND CUTANEOUS T-CELL LYMPHOMA DERIVED FROM A COMMON T-CELL CLONE
    DAVIS, TH
    MORTON, CC
    MILLERCASSMAN, R
    BALK, SP
    KADIN, ME
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (17) : 1115 - 1122
  • [5] Droc Claudia, 2007, Cancer Control, V14, P124
  • [6] FALINI B, 1995, BLOOD, V85, P1
  • [7] FISCHER P, 1988, BLOOD, V72, P234
  • [8] Forero A, 2005, J CLIN ONCOL, V23, p585S
  • [9] Gallardo F, 2004, ACTA DERMOSIFILIOGR, V95, P473
  • [10] The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative)
    Gellrich, S
    Wernicke, M
    Wilks, A
    Lukowsky, A
    Muche, JM
    Jasch, KC
    Audring, H
    Mason, D
    Sterry, W
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : 859 - 861